Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its fourth quarter and full-year 2024 financial results on Tuesday, February 25, ...

StockNews.com upgraded shares of Orthofix Medical (NASDAQ:OFIX – Free Report) from a hold rating to a buy rating in a report published on Friday. Other equities analysts have also recently issued ...

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its fourth quarter and full-year 2024 financial results on Tuesday ...

Canaccord Genuity initiates coverage on Orthofix Medical with a Buy rating and $24 price target, citing growth potential and strong financial outlook.

Fintel reports that on January 22, 2025, Canaccord Genuity initiated coverage of Orthofix Medical (NasdaqGS:OFIX) with a Buy ...

Shares of Orthofix Medical Inc. (NASDAQ:OFIX – Get Free Report) have been assigned an average rating of “Moderate Buy” from the five analysts that are covering the firm, MarketBeat.com reports.

Julie Andrews, Orthofix's CFO, sold 4,655 shares of common stock on Jan. 16, according to a Jan. 21 SEC filing.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

PORTLAND, IL, UNITED STATES, January 30, 2025 /EINPresswire / -- Increase in the number of spinal & joint <a target=_blank href= ...

DelveInsight Analysis: The Orthopedic Trauma Devices market size is expected to grow at a CAGR of 6.43% during the forecast period (201-26) to reach USD 10.08 billion by 2030. Which MedTech key ...